Brief: Bionano Informs On China NMPA Approval
22/02/2023 17:34
Feb 22 (Reuters) - Bionano Genomics Inc BNGO.O :
* BIONANO ANNOUNCES CHINA NMPA APPROVAL FOR DNA EXTRACTION
AND
LABELING PRODUCTS FOR IVD USE IN HEMATOLOGIC MALIGNANCIES
Source text for Eikon: ID:nGNXbxXzcv
Further company coverage: BNGO.O
Recent news on Bionano Genomics
See all newsBionano Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Bionano Genomics Q2 revenue rises on increased clinical adoption
Brief: Bionano Genomics Q2 Revenue USD 8.2 Million
Bionano Genomics, Inc. expected to post a loss of 68 cents a share - Earnings Preview
Bionano Genomics Q1 revenue up 4%, margin improves; to retire convertible debt